retatrutide ly3437943 glp-1 gip glucagon triple agonist (RETA) is one of the most promising investigational Retatrutide is the triple-agonist GLP-1

Weight loss is similar between drug classesnearly 2 kg (4 lb, 6 oz) with SGLT-2 inhibitors and 1.5 kg (3 lb, 5 oz) with GLP-1 receptor agonists

Results based on a randomized 12-week human clinical study (Study B, N=107)

GLP1 RA Mechanisms of Action and Weight Loss As of January 2025, there are three incretin mimetic medications approved for treatment of overweight and obesity: liraglutide, semaglutide, and tirzepatide

Westend Supplies Why choose Hospira brand Our manufacturing facility follows cGMP (Current Good Manufacturing Practice) standards, ensuring that the facility, equipment, personnel, and processes meet strict FDA regulatory requirements

Research suggests that increasing fiber-rich foods in our diet can help naturally stimulate GLP-1 (glucagon-like peptide-1) receptors